Powder: -20°C for 3 years | In solvent: -80°C for 1 year
D-NMAPPD ((1R,2R)-B13) is an acid ceramidase inhibitor. D-NMAPPD regulates the properties of NMDA receptor by enhancing the endogenous production of ceramides. D-NMAPPD has anticancer effecs [1] [2].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | 35 days | $ 73.00 | |
5 mg | 35 days | $ 268.00 | |
10 mg | 35 days | $ 493.00 | |
50 mg | 35 days | $ 1,930.00 |
Description | D-NMAPPD ((1R,2R)-B13) is an acid ceramidase inhibitor. D-NMAPPD regulates the properties of NMDA receptor by enhancing the endogenous production of ceramides. D-NMAPPD has anticancer effecs [1] [2]. |
In vitro | In rat hippocampal slices preincubated with the acid ceramidase inhibitor (ACI) d-NMAPPD, exhibits increased N-methyl-D-aspartate (NMDA) receptor-mediated field excitatory postsynaptic potentials (fEPSPs) in CA1 synapses [1]. |
Molecular Weight | 422.56 |
Formula | C23H38N2O5 |
CAS No. | 35922-06-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
D-NMAPPD 35922-06-6 D NMAPPD DNMAPPD inhibitor inhibit